Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
Sponsor: National Cancer Institute, Egypt
Summary
In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.
Official title: Comparative Study Between Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
Key Details
Gender
All
Age Range
3 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
128
Start Date
2025-01-15
Completion Date
2025-10-15
Last Updated
2025-08-11
Healthy Volunteers
No
Interventions
Nalbuphine
this group will a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)
Tramadol
this group will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).
Locations (1)
National cancer institute
Cairo, Egypt